-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Quality Improvement

Program: Trainee Activities and Services
Session: Blood Drop: Quality Improvement
Friday, December 9, 2022, 4:35 PM-4:45 PM
Friday, December 9, 2022, 4:50 PM-5:00 PM

Donald M. Arnold, MD

McMaster University, Hamilton, ON, Canada

Disclosures: Arnold: Novartis [ITP]; Rigel [ITP]; UCB [ITP]; Principia [ITP]; Amgen [ITP]; Medison [ITP], Daiichi Sankyo [ITP], Sobi [ITP], Chugai [ITP], Argenx [ITP]; Takeda [Hereditary TTP]: Consultancy; Novartis [ITP]; Rigel [ITP]: Research Funding.